U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07854847) titled 'Study Interchangeability Hep-B Vaccine Administered at Birth Dose' on Sept. 28.
Brief Summary: This trial is a randomized, double-blind, two arms parallel groups, prospective intervention study.
Study Start Date: Oct., 2026
Study Type: INTERVENTIONAL
Condition:
Vaccination Adverse Event
Immunogenicity, Vaccine
Intervention:
BIOLOGICAL: In-house Hepatitis B Vaccine
0,5 ml In-House Recombinant Hepatitis B (Bio Farma) vaccine injected approximately at birth. The vaccines will be injected intramuscularly into the right anterolateral thigh
BIOLOGICAL: Registered Hepatitis B Vaccine
0,5 ml Registered Recombinant Hepatitis B (Bio F...